Humana Inc HUM Q1 2026 Earnings Preview Revenue Growth Expected Amid Projected EPS Decline Upside Catalysts Remain EVCM EverCommerce delivers 277 percent EPS surprise for Q4 2025 shares climb nearly one percent Biogen Inc BIIB Secures Exclusive Global Felzartamab Rights via Greater China Licensing Deal Shares Rally OCCIM OFS Credit releases latest quarterly earnings results with no public analyst consensus estimates available for performance comparison